|
Parents with a family
history of a serious or
fatal genetic condition now
have the option of combining
IVF and genetic testing, in
a technique known as
pre-implantation genetic
diagnosis (PGD).
Couples using PGD first
need to use IVF procedures
to generate embryos. A
single cell can then be
removed from the very early
embryo without damaging it.
This cell can be tested to
see if it carries the
genetic defect that causes
the condition. Only embryos
that do not carry the
defective gene are implanted
in the mother.
While there has only been
limited use of PGD so far,
the potential applications
of PGD are increasing
rapidly, as researchers
identify more of the genes
associated with serious
genetic conditions.
As with all IVF
procedures, a successful
pregnancy is not guaranteed.
However, for many couples
who have experienced a
serious genetic condition or
lost family members, PGD is
more acceptable than using
prenatal genetic testing on
a growing baby, or not
having children at all.
Genetic testing in any
context raises many
significant issues for our
community, but particularly
when embryos are involved.
In general, PGD is usually
only permitted for serious
or life-threatening
conditions, and if it
improves the welfare and the
interests of the child being
born.
Some families have tested
embryos using PGD to ensure
they can provide a bone
marrow transplant for a sick
sibling. The bone marrow
cells for the sick sibling
are taken from the umbilical
cord blood of the new baby.
Using this process of tissue
typing, these babies are
sometimes called ‘saviour
siblings’, as they can
literally save their sick
brother or sister’s life.
Regulations regarding
this use of PGD testing vary
from country to country. In
Australia, some states have
PGD regulations, and others
do not. |